No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
VKTX241227C56000
- 0.16
- -0.14-46.67%
15min DelayClose Dec 20 16:00 ET
0.16High0.16Low
0.16Open0.30Pre Close2 Volume19 Open Interest56.00Strike Price32.00Turnover159.84%IV32.92%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.16Extrinsic Value100Contract SizeAmericanOptions Type0.0657Delta0.0172Gamma211.25Leverage Ratio-0.0967Theta0.0003Rho13.88Eff Leverage0.0060Vega
Intraday
- 5D
- Daily
News
Why Viking Therapeutics Tumbled by More Than 10% This Week
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know
Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla -- WSJ
B.Riley Financial Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $109
BTIG Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $125
B.Riley Financial Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)